Histopathologic comparison of human coronary instent and post-balloon angioplasty restenotic tissue - Moreno, PR; Palacios, IF; Leon, MN; Rhodes, J; Fuster, V; Fallon, JT (AMERICAN JOURNAL OF CARDIOLOGY, 1999)

Acute coronary syndromes: Pathophysiology and preventive priorities - Badimon J; Zaman A; Helft G; Fayad Z; Fuster V (THROMBOSIS AND HAEMOSTASIS, 1999)

Histopathology and pathogenesis of plaque instability and thrombus formation - Zaman, AG; Helft, G; Osende, JI; Fusfer, V; Badimon, JJ (DRUGS OF TODAY, 1999)

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle - Gallo, R; Padurean, A; Jayaraman, T; Marx, S; Rogue, M; Adelman, S; Chesebro, J; Fallon, J; Fuster, V; Marks, A; Badimon, JJ (CIRCULATION, 1999)

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease - Vorchheimer, DA; Badimon, JJ; Fuster, V (JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999)

Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques - Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions - Badimon, JJ; Lettino, M; Toschi, V; Fuster, V; Berrozpe, M; Chesebro, JH; Badimon, L (CIRCULATION, 1999)

The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures - Dangas G; Fuster V (Revista Portuguesa de Cardiologia, 1999)

Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes - Schussheim, AE; Fuster, V (DRUGS, 1999)

Epidemic of cardiovascular disease and stroke: The three main challenges - Presented at the 71st Scientific Sessions of the American Heart Association - Dallas, Texas - Fuster, V (CIRCULATION, 1999)

The American Stroke Association - A division of the American Heart Association - Fuster, V (STROKE, 1999)

Pathophysiology and clinical significance of atherosclerotic plaque rupture - Gutstein, DE; Fuster, V (CARDIOVASCULAR RESEARCH, 1999)

27ª Conferencia de Bethesda - Fuster, Valentí; Pearson, Thomas A (Tratamiento del paciente con riesgo cardiovascular, 1999)

Acute coronary syndromes: biology - Fuster, V; Fayad, ZA; Badimon, JJ (LANCET, 1999)

Medical treatment of the aorta I - Fuster V; Andrews P (CARDIOLOGY CLINICS, 1999)

Thrombosis and coagulation abnormalities in the acute coronary syndromes - Fischer A; Gutstein DE; Fuster V (CARDIOLOGY CLINICS, 1999)

AHA's renewed and stronger commitment to stroke - Fuster, V (STROKE, 1998)

Histopathology of coronary lesions with early loss of minimal luminal diameter after successful percutaneous transluminal coronary angioplasty: Is thrombus a significant contributor? - Moreno, PR; Fallon, JT; Bernardi, VH; Harrell, L; Weissman, NJ; Fuster, V; Rodríguez, A; Palacios, IF (AMERICAN HEART JOURNAL, 1998)

The relationships among dose, effectiveness, and side effects - Patrono, C; Coller, B; Dalen, JE; Fuster, V; Gent, M; Harker, LA; Hirsh, J; Roth, G (CHEST, 1998)

Antithrombotic therapy and venous graft disease - Schussheim, AE; Fuster, V (CURRENT OPINION IN CARDIOLOGY, 1998)

Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice - Fayad, ZA; Fallon, JT; Shinnar, M; Wehrli, S; Dansky, HM; Poon, M; Badimon, JJ; Charlton, SA; Fisher, EA; Breslow, JL; Fuster, V (CIRCULATION, 1998)

Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening - Badimon, JJ; Ortiz, AF; Meyer, B; Mailhac, A; Fallen, JT; Falk, E; Badimon, L; Chesebro, JH; Fuster, V (ATHEROSCLEROSIS, 1998)

Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries - Gertz, SD; Fallon, JT; Gallo, R; Taubman, MB; Banai, S; Barry, WL; Gimple, LW; Nemerson, Y; Thiruvikraman, S; Naidu, SS; Chesebro, JH; Fuster, V; et al. (CIRCULATION, 1998)

New cardiovascular training track: Reinventing the wheel? Response - Nash, IS; Fuster, V (ANNALS OF INTERNAL MEDICINE, 1998)

Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease - Harnick, DJ; Cohen, JL; Schechter, CB; Fuster, V; Smith, DA (AMERICAN JOURNAL OF CARDIOLOGY, 1998)

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: Results from the GUSTO-IIb trial - Metz, BK; White, HD; Granger, CB; Simes, RJ; Armstrong, PW; Hirsh, J; Fuster, V; MacAulay, CM; Califf, RM; Topol, EJ (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998)

Mechanisms of arterial thrombosis: Foundation for therapy - Fuster, V (AMERICAN HEART JOURNAL, 1998)

Elderly patients receive less aggressive medical and invasive management of unstable angina - Potential impact of practice guidelines - Giugliano, RP; Camargo, CA; Lloyd-Jones, DM; Zagrodsky, JD; Alexis, JD; Eagle, KA; Fuster, V; O'Donnell, CJ (ARCHIVES INTERNAL MEDICINE, 1998)

Acute coronary syndromes in the United States and United Kingdom: A comparison of approaches - Adams, PC; Skinner, JS; Cohen, M; McBride, R; Fuster, V (CLINICAL CARDIOLOGY, 1998)

Acute coronary syndromes - Unstable angina and non-Q-wave myocardial infarction - Théroux, P; Fuster, V (CIRCULATION, 1998)

Stable coronary artery disease - In reply - Fuster, V; Gutstein, DE (AMERICAN FAMILY PHYSICIAN, 1998)

Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction - Gutstein, DE; Fuster, V (CLINICAL CARDIOLOGY, 1998)

Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin - Comparison with heparin and aspirin - Meyer, BJ; Badimon, JJ; Chesebro, JH; Fallon, JT; Fuster, V; Badimon, L (CIRCULATION, 1998)

Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries - Gallo, R; Padurean, A; Toschi, V; Bichler, J; Fallon, JT; Chesebro, JH; Fuster, V; Badimon, JJ (CIRCULATION, 1998)

Oral platelet glycoprotein IIb/IIIa receptor antagonists: The present challenge is safety - Vorchheimer, DA; Fuster, V (CIRCULATION, 1998)

Behavior of atherosclerotic plaque components after in vitro angioplasty and atherectomy studied by high field MR imaging - Toussaint, JF; Southern, JF; Kantor, HL; Jang, IK; Fuster, V (MAGNETIC RESONANCE IMAGING, 1998)

The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses - Ambrose, JA; Fuster, V (HEART, 1998)

Infective endocarditis: New perspectives on an old disease - Fisher, EA; Fisher, LL; Fuster, V; Goldman, ME (Infectious Diseases in Clinical Practice, 1998)

Learning from the transgenic mouse - Endothelium, adhesive molecules, and neointimal formation - Fuster, V; Poon, M; Willerson, JT (CIRCULATION, 1998)

Revascularization in advanced stable coronary artery disease - Gutstein, DE; Fuster, V (DRUGS OF TODAY, 1998)

Pathobiology of coronary ischemic events: clinical implications. - Gallo R; Badimon J; Fuster V (ADVANCES IN INTERNAL MEDICINE, 1998)

Atherothrombosis: Mechanisms and clinical therapeutic approaches - Fuster V; Badimon J; Chesebro J (VASCULAR MEDICINE, 1998)

Impact of risk factor modification on the CHD process - Fuster, V (AMERICAN JOURNAL OF MANAGED CARE, 1997)

Present concepts of coronary atherosclerosis-thrombosis, therapeutic implications and perspectives - Fuster, V (ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1997)

Guidelines for management of left-sided prosthetic valve thrombosis: A role for thrombolytic therapy - Lengyel, M; Fuster, V; Keltai, M; Roudaut, R; Schulte, HD; Seward, JB; Chesebro, JH; Turpie, AGG (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997)

Sudden death in coronary artery disease - Acute ischemia versus myocardial substrate - Mehta, D; Curwin, J; Gomes, JA; Fuster, V (CIRCULATION, 1997)

Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease - Schussheim, AE; Fuster, V (PROGRESS IN CARDIOVASCULAR DISEASES, 1997)

Atherosclerosis: Imaging techniques and the evolving role of nuclear medicine - Vallabhajosula, S; Fuster, V (JOURNAL OF NUCLEAR MEDICINE, 1997)

Aspirin as a therapeutic agent in cardiovascular disease - A statement for healthcare professionals from the American Heart Association - Hennekens, CH; Dyken, ML; Fuster, V (CIRCULATION, 1997)

The generalist/cardiovascular specialist: A proposal for a new training track - Fuster, V; Nash, IS (ANNALS OF INTERNAL MEDICINE, 1997)

Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction - Fuster, V; Califf, RM; Chesebro, JH; Cohen, M; Comp, PC; Hall, J; Khan, S; Kopecky, S; Langer, A; Molk, B; OConnor, CM; OGara, PT; et al. (LANCET, 1997)

Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist - Badimon, JJ; Meyer, B; Feigen, LP; Baron, DA; Chesebro, JH; Fuster, V; Badimon, L (EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997)

The unstable atherosclerotic plaque: Clinical significance and therapeutic intervention - Fuster V; Fallon J; Badimon J; Nemerson Y (THROMBOSIS AND HAEMOSTASIS, 1997)

Management of stable coronary artery disease - Gutstein DE; Fuster V (AMERICAN FAMILY PHYSICIAN, 1997)

Restrictive cardiomyopathy - Reply - Kushwaha, SS; Fallon, JT; Fuster, V (NEW ENGLAND JOURNAL OF MEDICINE, 1997)

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction - Topol E; Califf R; Van der Werf F; Ardissino D; Armstrong PW; Bates E; Beatt K; Cheseboro J; Fuster V; Gibler WB; Gore J; Guerci A; et al. (NEW ENGLAND JOURNAL OF MEDICINE, 1997)

Do cardiologists do it better? - Nash, IS; Nash, DB; Fuster, V (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997)

Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance - Toussaint, JF; Southern, JF; Fuster, V; Kantor, HL (ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997)

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques - Toschi, V; Gallo, R; Lettino, M; Fallon, JT; Gertz, SD; FernandezOrtiz, A; Chesebro, JH; Badimon, L; Nemerson, Y; Fuster, V; Badimon, JJ (CIRCULATION, 1997)

Prevention of atherosclerosis in coronary-artery bypass grafts - Fuster, V; Vorchheimer, DA (NEW ENGLAND JOURNAL OF MEDICINE, 1997)

Medical progress - Restrictive cardiomyopathy - Kushwaha, SS; Fallon, JT; Fuster, V (NEW ENGLAND JOURNAL OF MEDICINE, 1997)

Can we predict future acute coronary events in patients with stable coronary artery disease? - Ambrose, JA; Fuster, V (JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997)

Coronary microcirculation in health and disease - Summary of an NHLBI Workshop - Chilian, WM; Bassingthwaighte, JB; Cannon, RO; Curry, FRE; Davis, MJ; Dellsperger, KC; Duling, BR; Fuster, V; Gerritsen, ME; Hoffman, JIE; Kajiya, F; Ku, DD; et al. (CIRCULATION, 1997)

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts - Campeau, L; Knatterud, GLMK; Domanski, M; Hunninghake, DB; White, CW; Geller, NL; Rosenberg, Y; Herd, A; Cocanougher, MK; Dunn, K; Farmer, J; Foreyt, J; et al. (NEW ENGLAND JOURNAL OF MEDICINE, 1997)

Pathogenesis of thrombosis in coronary artery disease - Chesebro, JH; Rauch, U; Fuster, V; Badimon, JJ (HAEMOSTASIS. INTERNATIONAL JOURNAL ON HAEMOSTASIS AND THROMBOSIS RESEARCH, 1997)

Human lesion studies - Fuster, V (Annals of the New York Academy of Sciences, 1997)

Optimal treatment for atrial fibrillation - Fuster V (Cardiovascular Reviews and Reports, 1997)

Prospective comparison of patient characteristics and outcome of non-prior aspirin users versus aspirin users with unstable angina or non-Q-wave myocardial infarction treated with combination antithrombotic therapy - Cohen M; Adams PC; McBride R; Blanke H; Fuster V (JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1997)

Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty - Smith A; Holt R; Fitzpatrick K; Palacios I; Gold H; Werner W; Bovill E; Fuster V; Jang I (ACC Current Journal Review, 1997)

Restrictive cardiomyopathy [5] - Reisinger J; Dubrey SW; Falk RH; Spodick DH; Kushwaha SS; Fallon JT; Fuster V (NEW ENGLAND JOURNAL OF MEDICINE, 1997)

Mecanismos das Síndromes Isquêmicas Agudas e da Progressao da Aterosclerose Coronária - Verri J; Fuster V (Arquivos Brasileiros de Cardiologia, 1997)

Aterosclerosis y enfermedad arterial coronaria - Fuster, Valentí; Russell, Ross; Topol, Eric J (1997)

Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina - Moreno, PR; Bernardi, VH; LopezCuellar, J; Newell, JB; McMellon, C; Gold, HK; Palacios, IF; Fuster, V; Fallon, JT (CIRCULATION, 1996)

Macrophages, smooth muscle cells, and tissue factor in unstable angina - Implications for cell-mediated thrombogenicity in acute coronary syndromes - Moreno, PR; Bernardi, VH; LopezCuellar, J; Murcia, AM; Palacios, IF; Gold, HK; Mehran, R; Sharma, SK; Nemerson, Y; Fuster, V; Fallon, JT (CIRCULATION, 1996)

Restenosis postangioplasty: Role of local drug delivery on its prevention - Badimon J; Gallo R; Badimon L; Chesebro J; Fuster V (CARDIOVASCULAR RISK FACTORS, 1996)

Current views on the pathophysiology of atherosclerosis - Badimon L; Badimon J; Fuster V (CARDIOVASCULAR RISK FACTORS, 1996)

Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide a and prothrombin fragment F1.2 in unstable angina - A multicenter trial - Rao, AK; Sun, L; Chesebro, JH; Fuster, V; Harrington, RA; Schwartz, D; Gallo, P; Matos, D; Topol, EJ (CIRCULATION, 1996)

Optimal antithrombotic therapy for mechanical prosthetic heart valves - Chesebro, JH; Fuster, V (CIRCULATION, 1996)

Fifty years of experience with antithrombotic therapy in cardiac disease - A 1996 approach based on pathogenesis and risk - Freudenberger R; Fuster V (Mount Sinai Journal of Medicine, 1996)

A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes - Topol E; Califf R; Granger C; Van De Werf F; Aylward P; Simes J; Col J; Armstrong P; Vahanian A; Neuhaus K; Rutsch W; Ardissino D; et al. (NEW ENGLAND JOURNAL OF MEDICINE, 1996)

Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo - Toussaint, JF; LaMuraglia, GM; Southern, JF; Fuster, V; Kantor, HL (CIRCULATION, 1996)

Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications - A statement for health professionals from the American Heart Association - Wexler, L; Brundage, B; Crouse, J; Detrano, R; Fuster, V; Maddahi, J; Rumberger, J; Stanford, W; White, R; Taubert, K (CIRCULATION, 1996)

Management of restenosis after coronary intervention - Dangas, G; Fuster, V (AMERICAN HEART JOURNAL, 1996)

Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology. - Smith S; Blair S; Criqui M; Fletcher G; Fuster V; Gersh B; Gotto A; Gould K; Greenland P; Grundy S; Hill M; Hlatky M; et al. (Cardio-vascular nursing, 1996)

Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors - Fuster, V; Gotto, AM; Libby, P; Loscalzo, J; McGill, HC (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996)

Management of patients with atrial fibrillation - A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association - Prystowsky, EN; Benson, DW; Fuster, V; Hart, RG; Kay, GN; Myerburg, RJ; Naccarelli, GV; Wyse, DG (CIRCULATION, 1996)

Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin - Mruk, JS; Zoldhelyi, P; Webster, MWI; Heras, M; Grill, DE; Holmes, DR; Fuster, V; Chesebro, JH (CIRCULATION, 1996)

Pathophysiology of coronary artery disease - FernandezOrtiz, A; Fuster, V (CLINICS IN GERIATRIC MEDICINE, 1996)

Plaque rupture, thrombosis, and therapeutic implications - Fuster, V; Badimon, J; Chesebro, JH; Fallon, JT (HAEMOSTASIS. INTERNATIONAL JOURNAL ON HAEMOSTASIS AND THROMBOSIS RESEARCH, 1996)

Hypercoagulable states and cardiovascular disease - McLaughlin M; Chesebro J; Fuster V (ACC Current Journal Review, 1996)

Cell biology of restenosis post-angioplasty - Badimon, L; Alfon, J; Royo, T; Berrozpe, M; MartinezGonzalez, J; Vidal, F; Chesebro, JH; Fuster, V; Badimon, JJ (ZEITSCHRIFT FUER KARDIOLOGIE, 1995)

ANGINA-PECTORIS AND DISEASE PROGRESSION - FALK, E; FUSTER, V (CIRCULATION, 1995)

T-2-WEIGHTED CONTRAST FOR NMR CHARACTERIZATION OF HUMAN ATHEROSCLEROSIS - TOUSSAINT, JF; SOUTHERN, JF; FUSTER, V; KANTOR, HL (ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995)

Acute myocardial infarction and the role of aspirin, heparin, and Warfarin - Chesebro J; Badimon J; Hassinger N; McBane R; Faster V (JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1995)

ELUCIDATION OF THE ROLE OF PLAQUE INSTABILITY AND RUPTURE IN ACUTE CORONARY EVENTS - FUSTER, V (AMERICAN JOURNAL OF CARDIOLOGY, 1995)

HUMAN MONOCYTE-DERIVED MACROPHAGES INDUCE COLLAGEN BREAKDOWN IN FIBROUS CAPS OF ATHEROSCLEROTIC PLAQUES - POTENTIAL ROLE OF MATRIX-DEGRADING METALLOPROTEINASES AND IMPLICATIONS FOR PLAQUE RUPTURE - Shah P; Falk E; Badimon J; Fernandez-Ortiz A; Mailhac A; Villareal- Levy G; Fallon J; Regnstrom J; Fuster V (CIRCULATION, 1995)

EVOLVING CONCEPTS IN THE PATHOGENESIS AND TREATMENT OF ARTERIAL THROMBOSIS - Chesebro J; Toschi V; Lettino M; Gallo R; Badimon J; Fallon J; Fuster V (Mount Sinai Journal of Medicine, 1995)

THE 3 MECHANISMS FOR CORONARY-ARTERY DISEASE PROGRESSION - INSIGHTS INTO FUTURE MANAGEMENT - MCLAUGHLIN, MA; FUSTER, V (Mount Sinai Journal of Medicine, 1995)

A DEFINITION OF ADVANCED TYPES OF ATHEROSCLEROTIC LESIONS AND A HISTOLOGICAL CLASSIFICATION OF ATHEROSCLEROSIS - A REPORT FROM THE COMMITTEE ON VASCULAR-LESIONS OF THE COUNCIL ON ARTERIOSCLEROSIS, AMERICAN-HEART-ASSOCIATION - STARY, HC; CHANDLER, AB; DINSMORE, RE; FUSTER, V; GLAGOV, S; INSULL, W; ROSENFELD, ME; SCHWARTZ, CJ; WAGNER, WD; WISSLER, RW; (CIRCULATION, 1995)

CORONARY PLAQUE DISRUPTION - FALK, E; SHAH, PK; FUSTER, V (CIRCULATION, 1995)

POTENTIAL APPLICATIONS OF IONTOPHORESIS FOR LOCAL-DRUG DELIVERY OF VASCULAR DISEASES - FERNANDEZORTIZ, A; MEYER, B; CHESEBRO, JH; FUSTER, V; BADIMON, JJ (JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1995)

PREVENTING HEART-ATTACK AND DEATH IN PATIENTS WITH CORONARY-DISEASE - SMITH, SC; BLAIR, SN; CRIQUI, MH; FLETCHER, GF; FUSTER, V; GERSH, BJ; GOTTO, AM; GOULD, KL; GREENLAND, P; GRUNDY, SM; HILL, MN; HLATKY, MA; et al. (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995)

THE 3 PROCESSES LEADING TO POST PTCA RESTENOSIS - DEPENDENCE ON THE LESION SUBSTRATE - FUSTER, V; FALK, E; FALLON, JT; BADIMON, L; CHESEBRO, JH; BADIMON, JJ (THROMBOSIS AND HAEMOSTASIS, 1995)

Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram - FUSTER, V; BADIMON, JJ (EUROPEAN HEART JOURNAL, 1995)

Aspirin for primary prevention of coronary disease - FUSTER, V; CHESEBRO, JH (EUROPEAN HEART JOURNAL, 1995)

IDIOPATHIC DILATED CARDIOMYOPATHY - REPLY - DEC, GW; FUSTER, V (NEW ENGLAND JOURNAL OF MEDICINE, 1995)

Idiopathic dilated cardiomyopathy - DEC, GW; FUSTER, V (NEW ENGLAND JOURNAL OF MEDICINE, 1995)

HIGH-RISK OF THROMBOEMBOLI EARLY AFTER BIOPROSTHETIC CARDIAC-VALVE REPLACEMENT - HERAS, M; CHESEBRO, JH; FUSTER, V; PENNY, WJ; GRILL, DE; BAILEY, KR; DANIELSON, GK; ORSZULAK, TA; PLUTH, JR; PUGA, FJ; SCHAFF, HV; LARSONKELLER, JJ (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995)

PRINZMETAL ANGINA AND CYPROHEPTADINE - IN RESPONSE - SCHECTER, AD; CHESEBRO, JH; FUSTER, V (ANNALS OF INTERNAL MEDICINE, 1995)

Coumadin aspirin reinfarction study: Rationale and design of the CARS study - Vorchheimer D; Fuster V (JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1995)

Prinzmetal angina and cyproheptadine [3] - Ambrus J; Schecter A; Chesebro J; Fuster V (ANNALS OF INTERNAL MEDICINE, 1995)

Erratum: Mechanisms leading to myocardial infarction: Insights from studies of vascular biology (Circulation (1994) 90 (2116-2146)) - Fuster V (CIRCULATION, 1995)

Erratum: Idiopathic dilated cardiomyopathy (New England Journal of Medicine) - Mishark K; Odawara M; Yamashita K; Legha S; Dec G; Fuster V (NEW ENGLAND JOURNAL OF MEDICINE, 1995)

Early identification of patients with native valve infectious endocarditis at risk for major complications by initial clinical presentation and baseline echocardiography - Goldman M; Fisher E; Winters S; Reichstein R; Stavile K; Gorlin R; Fuster V (INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995)

Cardiopatía isquémica: Cardona, 1995 - Eugene Braunwald; Valentí Fuster; S King (1995)

OPTIMAL RISK FACTOR MANAGEMENT IN THE PATIENT AFTER CORONARY REVASCULARIZATION - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM AN AMERICAN-HEART-ASSOCIATION WRITING GROUP - PEARSON, T; RAPAPORT, E; CRIQUI, M; FURBERG, C; FUSTER, V; HIRATZKA, L; LITTLE, W; OCKENE, I; WILLIAMS, G (CIRCULATION, 1994)

C-13-NMR SPECTROSCOPY OF HUMAN ATHEROSCLEROTIC LESIONS - RELATION BETWEEN FATTY-ACID SATURATION, CHOLESTERYL ESTER CONTENT, AND LUMINAL OBSTRUCTION - TOUSSAINT, JF; SOUTHERN, JF; FUSTER, V; KANTOR, HL (ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1994)

PERSISTENT THROMBIN GENERATION IN HUMANS DURING SPECIFIC THROMBIN INHIBITION WITH HIRUDIN - ZOLDHELYI, P; BICHLER, J; OWEN, WG; GRILL, DE; FUSTER, V; MRUK, JS; CHESEBRO, JH (CIRCULATION, 1994)

Left ventricular thromboembolism after myocardial infarction - Huggins G; Fuster V (Heart disease and stroke : a journal for primary care physicians, 1994)

MALPERFUSION OF THE THORACOABDOMINAL VASCULATURE IN AORTIC DISSECTION - DISCUSSION - BORST, HG; FUSTER, V; GOTT, VL; GRIEPP, RB; LANSMAN, SL; MILLER, DC (Journal of Cardiac Surgery, 1994)

INHIBITION OF GROWTH OF THROMBUS ON FRESH MURAL THROMBUS - TARGETING OPTIMAL THERAPY - MEYER, BJ; BADIMON, JJ; MAILHAC, A; FERNANDEZORTIZ, A; CHESEBRO, JH; FUSTER, V; BADIMON, L (CIRCULATION, 1994)

LOCAL-DELIVERY OF R-HIRUDIN BY A DOUBLE-BALLOON PERFUSION CATHETER PREVENTS MURAL THROMBOSIS AND MINIMIZES PLATELET DEPOSITION AFTER ANGIOPLASTY - MEYER, BJ; FERNANDEZORTIZ, A; MAILHAC, A; FALK, E; BADIMON, L; MICHAEL, AD; CHESEBRO, JH; FUSTER, V; BADIMON, JJ (CIRCULATION, 1994)

Aortic dissection: A medical perspective - FUSTER, V; HALPERIN, JL (Journal of Cardiac Surgery, 1994)

SAFETY AND ANTICOAGULATION EFFECT OF A LOW-DOSE COMBINATION OF WARFARIN AND ASPIRIN IN CLINICALLY STABLE CORONARY-ARTERY DISEASE - GOODMAN, SG; LANGER, A; DURICA, SS; RASKOB, GE; COMP, PC; GRAY, RJ; HALL, JH; KELLEY, RP; HUA, TA; LEE, RJ; FUSTER, V (AMERICAN JOURNAL OF CARDIOLOGY, 1994)

SYNERGISTIC ACTION OF SEVERE WALL INJURY AND SHEAR FORCES ON THROMBUS FORMATION IN ARTERIAL-STENOSIS - DEFINITION OF A THROMBOTIC SHEAR RATE THRESHOLD - MERINO, A; COHEN, M; BADIMON, JJ; FUSTER, V; BADIMON, L (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994)

RANDOMIZED TRIAL OF INTRAVENOUS HEPARIN VERSUS RECOMBINANT HIRUDIN FOR ACUTE CORONARY SYNDROMES - TOPOL, E; CALIFF, R; VANDEWERF, F; ARDISSINO, D; ARMSTRONG, P; AYLWARD, P; BARBASH, G; BATES, E; BEATT, K; BETRIU, A; CHESEBRO, J; COL, J; et al. (CIRCULATION, 1994)

MECHANISMS LEADING TO MYOCARDIAL-INFARCTION - INSIGHTS FROM STUDIES OF VASCULAR BIOLOGY - FUSTER, V (CIRCULATION, 1994)

PROSPECTIVE EVALUATION OF A PROSTACYCLIN-SPARING ASPIRIN FORMULATION AND HEPARIN WARFARIN IN ASPIRIN USERS WITH UNSTABLE ANGINA OR NON-Q-WAVE MYOCARDIAL-INFARCTION AT REST - COHEN, M; PARRY, G; ADAMS, PC; XIONG, J; CHAMBERLAIN, D; WIECZOREK, I; FOX, KAA; KRONMAL, R; FUSTER, V (EUROPEAN HEART JOURNAL, 1994)

TASK-FORCE-2 - ACADEMIC HEALTH CENTERS - KING, SB; FRYE, RL; FUSTER, V; GARSON, A; GAY, WA; POPP, RL (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994)

EFFECT OF AN ECCENTRIC SEVERE STENOSIS ON FIBRIN(OGEN) DEPOSITION ON SEVERELY DAMAGED VESSEL WALL IN ARTERIAL THROMBOSIS - RELATIVE CONTRIBUTION OF FIBRIN(OGEN) AND PLATELETS - MAILHAC, A; BADIMON, JJ; FALLON, JT; FERNANDEZORTIZ, A; MEYER, B; CHESEBRO, JH; FUSTER, V; BADIMON, L (CIRCULATION, 1994)

MACROPHAGE INFILTRATION IN ACUTE CORONARY SYNDROMES - IMPLICATIONS FOR PLAQUE RUPTURE - MORENO, PR; FALK, E; PALACIOS, IF; NEWELL, JB; FUSTER, V; FALLON, JT (CIRCULATION, 1994)

REFRACTORY PRINZMETAL ANGINA TREATED WITH CYPROHEPTADINE - SCHECTER, AD; CHESEBRO, JH; FUSTER, V (ANNALS OF INTERNAL MEDICINE, 1994)

DIAGNOSING AND MANAGING UNSTABLE ANGINA - BRAUNWALD, E; JONES, RH; MARK, DB; BROWN, J; BROWN, L; CHEITLIN, MD; CONCANNON, CA; COWAN, M; EDWARDS, C; FUSTER, V; GOLDMAN, L; GREEN, LA; et al. (CIRCULATION, 1994)

MURAMIDASE - A USEFUL MONOCYTE/MACROPHAGE IMMUNOCYTOCHEMICAL MARKER IN SWINE, OF SPECIAL INTEREST IN EXPERIMENTAL CARDIOVASCULAR-DISEASE - FALK, E; FALLON, JT; MAILHAC, A; FERNANDEZORTIZ, A; MEYER, BJ; WENG, D; SHAH, PK; BADIMON, JJ; FUSTER, V (CARDIOVASCULAR PATHOLOGY, 1994)

CHARACTERIZATION OF THE RELATIVE THROMBOGENICITY OF ATHEROSCLEROTIC PLAQUE COMPONENTS - IMPLICATIONS FOR CONSEQUENCES OF PLAQUE RUPTURE - FERNANDEZORTIZ, A; BADIMON, JJ; FALK, E; FUSTER, V; MEYER, B; MAILHAC, A; WENG, D; SHAH, PK; BADIMON, L (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994)

PLATELET DEPOSITION INDUCED BY SEVERELY DAMAGED VESSEL WALL IS INHIBITED BY A BOROARGININE SYNTHETIC PEPTIDE WITH ANTITHROMBIN ACTIVITY - BADIMON, JJ; WENG, D; CHESEBRO, JH; FUSTER, V; BADIMON, L (THROMBOSIS AND HAEMOSTASIS, 1994)

ANTIPLATELET AND ANTITHROMBIN THERAPY - FERNANDEZORTIZ, A; JANG, IK; FUSTER, V (CORONARY ARTERY DISEASE, 1994)

NEW APPROACH FOR LOCAL INTRAVASCULAR DRUG-DELIVERY - IONTOPHORETIC BALLOON - FERNANDEZORTIZ, A; MEYER, BJ; MAILHAC, A; FALK, E; BADIMON, L; FALLEN, JT; FUSTER, V; CHESEBRO, JH; BADIMON, JJ (CIRCULATION, 1994)

DOUBLE-BLIND COUMADIN RESEARCH - AN ETHICAL DILEMMA - REPLY - FUSTER, V; CALIFF, RM; CHESEBRO, JH (AMERICAN JOURNAL OF CARDIOLOGY, 1994)

RECOMBINANT HIRUDIN FOR UNSTABLE ANGINA-PECTORIS - A MULTICENTER, RANDOMIZED ANGIOGRAPHIC TRIAL - TOPOL, EJ; FUSTER, V; HARRINGTON, RA; CALIFF, RM; KLEIMAN, NS; KEREIAKES, DJ; COHEN, M; CHAPEKIS, A; GOLD, HK; TANNENBAUM, MA; RAO, AK; DEBOWEY, D; et al. (CIRCULATION, 1994)

GUIDE TO ANTICOAGULANT-THERAPY .1. HEPARIN - HIRSH, J; FUSTER, V (CIRCULATION, 1994)

GUIDE TO ANTICOAGULANT-THERAPY .2. ORAL ANTICOAGULANTS - HIRSH, J; FUSTER, V (CIRCULATION, 1994)

THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - GUSTO CRITICIZED - FUSTER, V (NEW ENGLAND JOURNAL OF MEDICINE, 1994)

ANTITHROMBOTIC THERAPY IN PROSTHETIC HEART-VALVE REPLACEMENT - ISRAEL, DH; SHARMA, SK; FUSTER, V (AMERICAN HEART JOURNAL, 1994)

RANDOMIZED TRIAL OF RIDOGREL, A COMBINED THROMBOXANE A(2) SYNTHASE INHIBITOR AND THROMBOXANE A(2)/PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST, VERSUS ASPIRIN AS ADJUNCT TO THROMBOLYSIS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - THE RIDOGREL VERSUS ASPIRIN PATENCY TRIAL (RAPT) - VANDEWERF, F; SANTOPINTO, J; CORDERO, FA; FAINSTEIN, D; CORINALDESI, A; ZAVATTI, D; LUPPI, O; IPARRAGUIRRE, HP; HIRSCHSON, A; PIOMBO, A; LAPUENTE, A; KRITZER, J; et al. (CIRCULATION, 1994)

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS - ALTMAN, R; CARRERAS, L; DIAZ, R; FIGUEROA, E; PAOLASSO, E; PARODI, JC; CADE, JF; DONNAN, G; EADIE, MJ; GAVAGHAN, TP; OSULLIVAN, EF; PARKIN, D; et al. (BMJ-British Medical Journal, 1994)

ACUTE BIOLOGICAL RESPONSE TO LASER BALLOON ANGIOPLASTY IN THE ATHEROSCLEROTIC RABBIT - ALEXOPOULOS, D; SANBORN, TA; MARMUR, JD; BADIMON, JJ; BADIMON, L; DISCHE, R; FUSTER, V (LASERS IN SURGERY AND MEDICINE, 1994)

COMBINATION ANTITHROMBOTIC THERAPY IN UNSTABLE REST ANGINA AND NON-Q-WAVE INFARCTION IN NONPRIOR ASPIRIN USERS - PRIMARY END-POINTS ANALYSIS FROM THE ATACS TRIAL - COHEN, M; ADAMS, PC; PARRY, G; XIONG, J; CHAMBERLAIN, D; WIECZOREK, I; FOX, KAA; CHESEBRO, JH; STRAIN, J; KELLER, C; KELLY, A; LANCASTER, G; et al. (CIRCULATION, 1994)

Atherosclerotic disease: Role of thrombosis on its progression - Badimon J; Badimon L; Fuster V (CARDIOVASCULAR RISK FACTORS, 1994)

Intrinsic thrombus modifications favouring embolization. - Badimon L; Royo T; Badimon J; Chesebro J; Fuster V (Giornale Italiano di Cardiologia, 1994)

At the funeral service for Dr. Simon Dack, the following remarks were delivered by William D. Nelligan, former Executive Vice President of the College, and by Dr. Valentin Fuster, of the Cardiovascular Institute at Mount Sinai Medical Center - Fuster V (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994)

Thrombosis on atherosclerotic lesions: Implications for therapy - Badimon L; Fuster V; Fernandez-Ortiz A; Meyer B; Mailhac A; Pueyo C; Royo T; Badimon J (JOURNAL OF VASCULAR SURGERY, 1994)

CONJUNCTIVE ANTITHROMBOTIC THERAPY FOR THROMBOLYSIS IN MYOCARDIAL-INFARCTION - CHESEBRO, JH; BADIMON, JJ; ORTIZ, AF; MEYER, BJ; FUSTER, V (AMERICAN JOURNAL OF CARDIOLOGY, 1993)

CIRCULATING AND TISSUE ENDOTHELIN IMMUNOREACTIVITY IN HYPERCHOLESTEROLEMIC PIGS - LERMAN, A; WEBSTER, MWI; CHESEBRO, JH; EDWARDS, WD; WEI, CM; FUSTER, V; BURNETT, JC (CIRCULATION, 1993)

Arterial angioplasty: Thrombosis and restenosis - Badimon L; Chesebro J; Badimon J; Fuster V (JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1993)

Atherosclerosis and thrombosis in the coronary arteries - Badimon L; Badimon J; Fuster V (CARDIOVASCULAR RISK FACTORS, 1993)

PROSPECTIVE COMPARISON OF UNSTABLE ANGINA VERSUS NON-Q-WAVE MYOCARDIAL-INFARCTION DURING ANTITHROMBOTIC THERAPY - COHEN, M; XIONG, J; PARRY, G; ADAMS, PC; CHAMBERLAIN, D; WIECZOREK, I; FOX, KAA; MCBRIDE, R; CHESEBRO, JH; FUSTER, V; KELLER, C; KRONMAL, R; et al. (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993)

THE NEED FOR CORONARY SURGERY IN 1993 - KUSHWAHA, S; FUSTER, V (CURRENT OPINION IN CARDIOLOGY, 1993)

RECOMBINANT HIRUDIN IN PATIENTS WITH CHRONIC, STABLE CORONARY-ARTERY DISEASE - SAFETY, HALF-LIFE, AND EFFECT ON COAGULATION PARAMETERS - ZOLDHELYI, P; WEBSTER, MWI; FUSTER, V; GRILL, DE; GASPAR, D; EDWARDS, SJ; CABOT, CF; CHESEBRO, JH (CIRCULATION, 1993)

PROSTACYCLIN (EPOPROSTENOL) AND HEART-LUNG TRANSPLANTATION AS TREATMENTS FOR SEVERE PULMONARY-HYPERTENSION - Higenbottam T; Spiegelhalter D; Scott J; Fuster V; Dinh-Xuan A; Caine N; Wallwork J (BRITISH HEART JOURNAL, 1993)

CORONARY THROMBOLYSIS - A PERSPECTIVE FOR THE PRACTICING PHYSICIAN - FUSTER, V (NEW ENGLAND JOURNAL OF MEDICINE, 1993)

LONG-TERM OUTCOME IN PATIENTS UNDERGOING SURGICAL REPAIR OF TETRALOGY OF FALLOT - MURPHY, JG; GERSH, BJ; MAIR, DD; FUSTER, V; MCGOON, MD; ILSTRUP, DM; MCGOON, DC; KIRKLIN, JW; DANIELSON, GK (NEW ENGLAND JOURNAL OF MEDICINE, 1993)

ASPIRIN - OPTIMAL DOSE IN STROKE PREVENTION - RESPONSE - DYKEN, ML; BARNETT, HJM; EASTON, JD; FIELDS, WS; FUSTER, V; HACHINSKI, V; NORRIS, JW; SHERMAN, DG (STROKE, 1993)

PSYCHOLOGICAL CHANGES AFTER HEART-SURGERY - PRELIMINARY-STUDY - DENBER, HCB; FUSTER, V; ERGIN, MA; SCHMUZIGER, M (ANNALES MEDICO-PSYCHOLOGIQUES, 1993)

VON-WILLEBRAND-FACTOR AND CARDIOVASCULAR-DISEASE - Badimon L; Badimon J; Chesebro J; Fuster V (THROMBOSIS AND HAEMOSTASIS, 1993)

ARE BOTH ASPIRIN AND HEPARIN JUSTIFIED AS ADJUNCTS TO THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - RIDKER, PM; HEBERT, PR; FUSTER, V; HENNEKENS, CH (LANCET, 1993)

CORONARY ATHEROSCLEROSIS - A MULTIFACTORIAL DISEASE - Badimon J; Fuster V; Chesebro J; Badimon L (CIRCULATION, 1993)

LOW-DOSE ASPIRIN AND STROKE - RESPONSE - DYKEN, ML; BARNETT, HJM; EASTON, JD; FIELDS, WS; FUSTER, V; HACHINSKI, V; NORRIS, JW; SHERMAN, DG (STROKE, 1993)

ASPIRIN AS A THERAPEUTIC AGENT IN CARDIOVASCULAR-DISEASE - FUSTER, V; DYKEN, ML; VOKONAS, PS; HENNEKENS, C (CIRCULATION, 1993)

EXOGENOUS PROSTACYCLIN DECREASES VASOCONSTRICTION BUT NOT PLATELET THROMBUS DEPOSITION AFTER ARTERIAL INJURY - LAM, JYT; CHESEBRO, JH; BADIMON, L; FUSTER, V (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993)

Pathophysiology of restenosis: The role of platelets and thrombin - Marmur J; Taubman M; Fuster V (Journal of Vascular Medicine and Biology, 1993)

Psychological changes after heart surgery - Denber H; Fuster V; Ergin M; Schmuziger M (ANNALES MEDICO-PSYCHOLOGIQUES, 1993)

Low-dose aspirin and stroke [1] - Van Gijn J; Warlow C; Norrving B; Dyken M; Barnett H; Easton J; Fields W; Fuster V; Hachinski V; Norris J; Sherman D (STROKE, 1993)

ROLE OF HIGH-DENSITY-LIPOPROTEINS IN THE REGRESSION OF ATHEROSCLEROSIS - Badimon J; Fuster V; Badimon L (CIRCULATION, 1992)

CLINICAL-PATHOLOGICAL CORRELATIONS OF CORONARY-DISEASE PROGRESSION AND REGRESSION - Fuster V; Badimon J; Badimon L (CIRCULATION, 1992)

ECHOCARDIOGRAPHIC SMOKE IS PRODUCED BY AN INTERACTION OF ERYTHROCYTES AND PLASMA-PROTEINS MODULATED BY SHEAR FORCES - MERINO, A; HAUPTMAN, P; BADIMON, L; BADIMON, JJ; COHEN, M; FUSTER, V; GOLDMAN, M (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992)

Coronary atherosclerosis: Morphology and characteristics to identify by evolving imaging technology - Badimon L; Badimon J; Gold H; Fuster V (American Journal of Cardiac Imaging, 1992)

RECERTIFICATION IN CARDIOVASCULAR-DISEASE - CHEITLIN, MD; BELLER, GA; BRUNDAGE, BH; CONTI, R; DEMARIA, AN; FUSTER, V; HUNT, SA; RYAN, TJ; ZIPES, DP; LANGDON, LO (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992)

ANTIPLATELETS - JANG, IK; FUSTER, V; GOLD, HK (CORONARY ARTERY DISEASE, 1992)

ANTITHROMBINS AS CONJUNCTIVE THERAPY IN ARTERIAL THROMBOLYSIS - ZOLDHELYI, P; FUSTER, V; CHESEBRO, JH (CORONARY ARTERY DISEASE, 1992)

EXPANDED USE OF THROMBOLYTIC THERAPY - CURWIN, J; JANG, IK; FUSTER, V (MAYO CLINIC PROCEEDINGS, 1992)

LOW-DOSE ASPIRIN AND STROKE - IT AINT NECESSARILY SO - DYKEN, ML; BARNETT, HJM; EASTON, JD; FIELDS, WS; FUSTER, V; HACHINSKI, V; NORRIS, JW; SHERMAN, DG (STROKE, 1992)

ASPIRIN AND OTHER PLATELET-ACTIVE DRUGS - THE RELATIONSHIP BETWEEN DOSE, EFFECTIVENESS, AND SIDE-EFFECTS - HIRSH, J; DALEN, JE; FUSTER, V; HARKER, LB; SALZMAN, EW (CHEST, 1992)

COD LIVER OIL ALTERS PLATELET ARTERIAL-WALL RESPONSE TO INJURY IN PIGS - LAM, JYT; BADIMON, JJ; ELLEFSON, RD; FUSTER, V; CHESEBRO, JH (CIRCULATION RESEARCH, 1992)

BASIC STUDIES ON THROMBOSIS AND FIBRINOLYSIS - JANG, IK; GOLD, HK; FUSTER, V (CURRENT OPINION IN CARDIOLOGY, 1992)

THROMBOSIS IN UNSTABLE ANGINA - CHESEBRO, JH; FUSTER, V (NEW ENGLAND JOURNAL OF MEDICINE, 1992)

THE CLINICAL COURSE OF IDIOPATHIC DILATED CARDIOMYOPATHY - A POPULATION-BASED STUDY - SUGRUE, DD; RODEHEFFER, RJ; CODD, MB; BALLARD, DJ; FUSTER, V; GERSH, BJ (ANNALS OF INTERNAL MEDICINE, 1992)

UNSTABLE ANGINA - OUTCOME ACCORDING TO CLINICAL PRESENTATION - BETRIU, A; HERAS, M; COHEN, M; FUSTER, V (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992)

ENDOTHELIUM AND ATHEROSCLEROSIS - Badimon L; Badimon J; Penny W; Webster M; Chesebro J; Fuster V (JOURNAL OF HYPERTENSION, 1992)

A DILEMMA FOR THE 1990S - CHOOSING APPROPRIATE EXPERIMENTAL ANIMAL-MODEL FOR THE PREVENTION OF RESTENOSIS - FERRELL, M; FUSTER, V; GOLD, HK; CHESEBRO, JH (CIRCULATION, 1992)

ANTITHROMBOTIC EFFICACY OF LOW-MOLECULAR-WEIGHT HEPARIN IN DEEP ARTERIAL INJURY - HERAS, M; CHESEBRO, JH; WEBSTER, MWI; MRUK, JS; GRILL, DE; FUSTER, V (ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1992)

MECHANISMS OF DISEASE - THE PATHOGENESIS OF CORONARY-ARTERY DISEASE AND THE ACUTE CORONARY SYNDROMES .2. - FUSTER, V; BADIMON, L; BADIMON, JJ; CHESEBRO, JH (NEW ENGLAND JOURNAL OF MEDICINE, 1992)

The pathogenesis of coronary artery disease and the acute coronary syndromes - Epstein F; Fuster V; Badimon L; Badimon J; Chesebro J (NEW ENGLAND JOURNAL OF MEDICINE, 1992)

Cardiopatía isquémica: jornadas con el Dr. Fuster, Cardona; 1991 - Fuster, Valentí; Vázquez de Prada, José Antonio; Pajarón López, Antonio; San José, J María (1992)

PREDICTORS OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION .2. ECHOCARDIOGRAPHIC FEATURES OF PATIENTS AT RISK - ANDERSON, DC; ASINGER, RW; NEWBURG, SM; FARMER, CC; WANG, K; BUNDLIE, SR; KOLLER, RL; JAGIELLA, WM; KREHER, S; JORGENSEN, CR; SHARKEY, SW; FLAKER, GC; et al. (ANNALS OF INTERNAL MEDICINE, 1992)

PREDICTORS OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION .1. CLINICAL-FEATURES OF PATIENTS AT RISK - ANDERSON, DC; ASINGER, RW; NEWBURG, SM; FARMER, CC; WANG, K; BUNDLIE, SR; KOLLER, RL; JAGIELLA, WM; KREHER, S; JORGENSEN, CR; SHARKEY, SW; FLAKER, GC; et al. (ANNALS OF INTERNAL MEDICINE, 1992)

Diagnosis of pulmonary artery hypertension. - Weissman N; Fuster V (Heart disease and stroke : a journal for primary care physicians, 1992)

Congenital absence of the pericardium - Fisher D; Fisher J; Fisher E; Fuster V (Primary Cardiology, 1991)

CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS AND OUTCOME OF PATIENTS WITH REST-UNSTABLE ANGINA OCCURRING DURING REGULAR ASPIRIN USE - COHEN, M; MERINO, A; HAWKINS, L; GREENBERG, S; FUSTER, V (JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991)

PLAQUE DISRUPTION AND THROMBOSIS IN UNSTABLE ANGINA-PECTORIS - CHESEBRO, JH; ZOLDHELYI, P; FUSTER, V (AMERICAN JOURNAL OF CARDIOLOGY, 1991)

PATHOGENESIS OF THROMBOSIS IN UNSTABLE ANGINA - CHESEBRO, JH; ZOLDHELYI, P; FUSTER, V (AMERICAN JOURNAL OF CARDIOLOGY, 1991)